Onychomycosis, a persistent fungal infection that targets the nails, presents unique challenges in medical care—not because it threatens life, but because it can profoundly impact daily comfort, mobility, and confidence while proving remarkably stubborn to eliminate completely.

Why Treating Nail Fungus Matters More Than Appearance

When people discover thickened, yellowed nails with a crumbling texture, they often dismiss it as merely cosmetic. However, onychomycosis—the medical term for fungal nail infection—deserves attention for reasons that extend far beyond looks. This condition affects approximately one in ten adults overall, but becomes dramatically more common with age, affecting one in two people over 70 years old.^[1]

The main goals of treating onychomycosis focus on stopping the infection from spreading, reducing discomfort, and restoring the nail’s normal appearance. Treatment choices depend heavily on how severe the infection is, which nails are affected, and whether someone has other health conditions like diabetes or poor circulation. Medical professionals now have both well-established treatments approved by health authorities and access to ongoing research exploring new therapeutic approaches, including drugs currently being tested in clinical trials.

Although the infection itself doesn’t usually cause serious systemic illness, leaving it untreated can lead to genuine problems. The infection may cause pain that interferes with standing, walking, or exercising. For people with diabetes or weakened immune systems, untreated nail fungus can become a gateway for more serious infections, including cellulitis of the lower leg or even bone infections.^[3] Beyond physical symptoms, many people experience embarrassment about their nail appearance, which can affect their willingness to participate in activities where feet are visible.

Understanding Which Fungus Causes the Problem

Not all nail fungus comes from the same source. A type of mold called a dermatophyte (a fungus that feeds on keratin, the protein that makes nails hard) causes approximately 90% of toenail fungal infections. The most common culprit is Trichophyton rubrum, though other dermatophytes like Trichophyton mentagrophytes and Epidermophyton floccosum also cause infections.^[3]

The remaining cases involve yeasts (particularly Candida albicans, which accounts for about 2% of cases and more commonly affects fingernails) or nondermatophyte molds such as Fusarium, Aspergillus, Acremonium, and Scopulariopsis brevicaulis. These saprophytic molds account for roughly 8% of nail infections and are more prevalent in people with compromised immune systems.^[3] Interestingly, some research shows that 39% of infections may be “mixed,” meaning they involve dermatophytes plus nondermatophyte molds or yeasts together, which can complicate treatment decisions.^[15]

Standard Treatment Approaches That Doctors Recommend

Treating onychomycosis requires patience, as the infection sits beneath or within the nail itself, and nails grow very slowly. Fingernails take three to six months to grow out completely, while toenails require 12 to 18 months.^[12] Because of this, treatments need to continue for extended periods to allow a new, healthy nail to replace the infected one.

Oral Antifungal Medications

Oral medications taken by mouth represent the most effective standard treatment for onychomycosis. The primary drugs used are terbinafine (brand name Lamisil) and itraconazole (brand name Sporanox). These medications work by penetrating the nail plate and nail bed, attacking the fungus from within as a new nail grows out.

Terbinafine is generally considered the first-line choice because it shows the highest cure rates. Meta-analyses of research studies have found mycotic cure rates (meaning the fungus is eliminated) of 76% for terbinafine, compared to 63% for itraconazole with pulse dosing, 59% for itraconazole with continuous dosing, and 48% for fluconazole.^[4] Patients typically take terbinafine daily for six to twelve weeks, though the final result won’t be visible until the nail completely regrows—which may take four months or longer.

Itraconazole offers an alternative approach with intermittent pulse dosing. Instead of taking the medication every day for months, patients take it for one week per month, repeating for several cycles. This pulse dosing is as safe and effective as continuous therapy but proves more economical and convenient for many people.^[10]

Fluconazole, while not officially approved by the FDA specifically for onychomycosis, has shown promising early results in treating nail fungus. However, it demonstrates lower cure rates compared to terbinafine and itraconazole.^[10]

Despite the effectiveness of these treatments, success rates remain well below 100%, and the infection returns in 10% to 50% of cases. This happens either because the fungus wasn’t completely eliminated or because of reinfection from the environment.^[10] Treatment success rates also appear lower in adults over age 65.^[11]

Topical Antifungal Treatments

Topical treatments—medications applied directly to the nail—offer an alternative for people with mild to moderate infections, particularly when less than half of the nail is involved. These treatments avoid the systemic side effects and drug interactions associated with oral medications, but they’re generally less effective because they struggle to penetrate deeply enough into the nail.

Three main topical agents are approved for use: ciclopirox 8% nail lacquer (applied like nail polish), efinaconazole 10% solution, and tavaborole 5% solution. Ciclopirox requires daily application for up to 48 weeks and has a failure rate exceeding 60%, meaning it doesn’t work for the majority of patients.^[4] Efinaconazole, applied daily for the same duration, achieved complete cure in about 15-18% of patients in clinical trials, with mycologic cure (eliminating the fungus without necessarily restoring perfect nail appearance) in 53-55% of patients.^[13] Tavaborole showed complete cure rates of 6.5-9.1% and mycologic cure in 31-36% of patients.^[13]

Topical therapy works best for superficial infections or early distal infections that haven’t spread extensively. Outside the United States, amorolfine and bifonazole/urea combinations are also available as topical treatments.^[13]

Combination Approaches and Supportive Care

Many experts now recommend combining treatments to improve outcomes. Using both oral and topical antifungals together increases cure rates beyond either approach alone.^[13] Additionally, nail trimming and debridement (carefully removing thickened nail material and debris) used alongside medication significantly improves treatment response by reducing the amount of infected material and allowing better penetration of topical agents.^[15]

For patients who cannot tolerate systemic therapy or prefer not to use topical medications consistently, periodic debridement alone represents a viable management option, though it doesn’t cure the infection—it merely keeps it controlled and improves appearance.^[3]

Innovative Treatments Being Explored in Clinical Research

While standard treatments help many patients, the relatively modest cure rates and high recurrence rates have motivated researchers to explore new therapeutic approaches. Several innovative treatments are being investigated in clinical trials around the world.

Laser and Light-Based Therapies

Laser treatment represents one of the most actively researched new approaches for onychomycosis. Several types of lasers have been tested, including 1064nm Nd:YAG lasers (both short-pulsed and Q-switched versions), carbon dioxide lasers, and diode lasers operating at 870 and 930nm wavelengths.^[14] These lasers work by targeting the nail and underlying tissue with focused energy, with the goal of killing fungal cells through heat without damaging surrounding healthy tissue.

Clinical trials examining laser therapy have produced mixed results. Some studies have shown promising outcomes when laser treatment is combined with topical or oral antifungal medications, potentially enhancing the effectiveness of standard therapy.^[13] However, experts note that larger, well-designed randomized trials are still needed to establish exactly how effective laser therapy is as a standalone treatment or in combination approaches.^[15]

Photodynamic therapy, which combines light exposure with light-activated chemical compounds, is another light-based approach being investigated. This method involves applying a photosensitizing agent to the nail, then exposing it to specific wavelengths of light that activate the compound to produce substances toxic to fungal cells. Like laser therapy, photodynamic therapy shows promise based on laboratory studies, but requires more extensive clinical research to determine its real-world effectiveness.^[15]

Plasma Therapy

Plasma therapy is an emerging treatment modality being explored for onychomycosis. This approach uses ionized gas (plasma) to treat infected nails. While the exact mechanisms are still being studied, plasma may work by creating reactive chemical species that damage fungal cells or by enhancing the penetration of other treatments. Research into plasma therapy for nail fungus is still in relatively early stages, and larger randomized trials are needed to determine whether it offers meaningful benefits to patients.^[14]

New Formulations and Delivery Systems

Researchers are also working on improving how antifungal medications reach the site of infection. Since poor nail penetration is a major limitation of topical treatments, scientists are developing new formulations and delivery systems designed to carry medications through the hard nail plate more effectively. These include specialized nail lacquers, solutions with penetration enhancers, and even devices that create temporary micropores in the nail to allow better medication delivery. While many of these approaches are being tested, they haven’t yet reached the stage of large-scale clinical trials in most cases.

Alternative and Complementary Therapies

Various supplements and non-prescription treatments have been evaluated for onychomycosis. Tea tree oil, vinegar soaks, and various herbal preparations have been studied, though rigorous clinical evidence supporting their effectiveness remains limited. Some over-the-counter topical preparations containing antifungal compounds are marketed for nail fungus, but their cure rates are generally low.^[14] Patients interested in these approaches should discuss them with their healthcare provider, particularly if using them instead of or alongside prescription medications.

Most common treatment methods

• Oral antifungal medications
  • Terbinafine taken daily for 6-12 weeks with 76% cure rates
  • Itraconazole with pulse dosing (one week per month for several cycles) showing 63% cure rates
  • Fluconazole with lower effectiveness but showing promise in early studies
  • Liver function monitoring required during treatment
• Topical antifungal solutions
  • Ciclopirox 8% nail lacquer applied daily for up to 48 weeks
  • Efinaconazole 10% solution with complete cure rates of 15-18%
  • Tavaborole 5% solution with complete cure rates of 6.5-9.1%
  • Best suited for mild to moderate infections affecting less than half the nail
• Combination therapy
  • Using oral and topical antifungals together to increase cure rates
  • Combining medication with regular nail debridement and trimming
  • Laser treatment used alongside topical or oral medications
• Laser therapy
  • 1064nm Nd:YAG lasers targeting infected tissue with focused energy
  • Carbon dioxide lasers and diode lasers being tested in clinical trials
  • Works by heating and destroying fungal cells without damaging surrounding tissue
  • More clinical research needed to establish effectiveness
• Physical management
  • Regular nail trimming and filing to reduce infected material
  • Periodic debridement removing thickened nail and debris
  • Used alone for patients unable to take systemic medications
  • Improves appearance and reduces discomfort even without cure

Managing Expectations and Preventing Recurrence

One of the most challenging aspects of onychomycosis treatment is managing realistic expectations. Even with the best available therapies, complete cure rates rarely exceed 75-80%, and many patients see improvement rather than complete elimination of the infection. Furthermore, recurrence rates range from 10% to 50% even after apparently successful treatment.^[10] This happens because fungal spores persist in the environment—in shoes, socks, and common areas like locker rooms and pools—making reinfection likely unless preventive measures are taken.

To reduce the risk of recurrence or initial infection, healthcare providers recommend several practical steps. Keeping feet clean and completely dry is fundamental, as fungi thrive in warm, moist environments. Changing socks regularly and choosing breathable fabrics that wick moisture away from the skin helps keep feet dry. Selecting shoes that allow proper ventilation rather than trapping moisture makes a significant difference.^[1]

Wearing protective footwear like flip-flops in public showers, locker rooms, and around swimming pools reduces exposure to fungal spores. Disinfecting shoes with antifungal sprays or powders, and not reusing old shoes after successful treatment, helps prevent reinfection. Some experts recommend disposing of shoes worn during an active infection once treatment is complete.^[17]

Special Considerations for Different Patient Groups

Treatment approaches may need adjustment based on individual patient circumstances. People with diabetes face higher risks of complications from nail fungus, including progression to more serious foot infections. For these patients, even mild onychomycosis warrants treatment consideration, and careful foot monitoring is essential. Healthcare providers may need to coordinate care between multiple specialists.^[3]

Older adults, who are most commonly affected by onychomycosis, may have multiple other health conditions and take various medications. This makes drug interactions a significant concern when considering oral antifungal therapy. Additionally, treatment success rates appear somewhat lower in people over 65, possibly due to slower nail growth and reduced immune function.^[11]

People with weakened immune systems—whether from HIV infection, cancer treatment, organ transplantation, or autoimmune diseases—face not only higher infection rates but also more severe infections that are harder to treat. Proximal subungual onychomycosis, which starts at the base of the nail, is actually considered a marker of immunosuppression.^[3] These patients typically require systemic therapy and close medical supervision.

For pregnant or breastfeeding women, treatment options become more limited, as oral antifungal medications are generally not recommended during pregnancy. In these cases, healthcare providers may suggest waiting until after pregnancy and nursing to pursue treatment, or using conservative measures like nail trimming if the infection causes significant discomfort.

The Financial and Practical Reality of Treatment

Cost considerations affect treatment decisions significantly. Oral medications like terbinafine and itraconazole can be expensive, though generic versions have made them more affordable. Newer topical agents like efinaconazole and tavaborole tend to cost more than older topical treatments. Laser therapy, typically not covered by insurance as it’s often considered cosmetic, can be prohibitively expensive for many patients.^[14]

The lengthy treatment duration also factors into practical considerations. Taking daily medication or applying topical treatments consistently for many months requires significant commitment. Patient adherence—actually following through with the treatment as prescribed—is a major factor in treatment success. Pulse dosing with itraconazole offers one approach to making treatment more manageable by reducing the number of days patients need to remember medication.^[10]